- Home
- WHWK vs NAUT Comparison
WHWK vs NAUT Comparison
Compare WHWK & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- NAUT
- Stock Information
- Founded
- WHWK 2007
- NAUT 2016
- Country
- WHWK United States
- NAUT United States
- Employees
- WHWK N/A
- NAUT N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- WHWK Health Care
- NAUT Industrials
- Exchange
- WHWK Nasdaq
- NAUT Nasdaq
- Market Cap
- WHWK 87.6M
- NAUT 91.5M
- IPO Year
- WHWK N/A
- NAUT N/A
- Fundamental
- Price
- WHWK $1.94
- NAUT $0.76
- Analyst Decision
- WHWK
- NAUT Strong Sell
- Analyst Count
- WHWK 0
- NAUT 1
- Target Price
- WHWK N/A
- NAUT $1.75
- AVG Volume (30 Days)
- WHWK 148.4K
- NAUT 555.0K
- Earning Date
- WHWK 08-15-2025
- NAUT 07-31-2025
- Dividend Yield
- WHWK N/A
- NAUT N/A
- EPS Growth
- WHWK N/A
- NAUT N/A
- EPS
- WHWK 0.91
- NAUT N/A
- Revenue
- WHWK $27,775,000.00
- NAUT N/A
- Revenue This Year
- WHWK $49.83
- NAUT N/A
- Revenue Next Year
- WHWK N/A
- NAUT N/A
- P/E Ratio
- WHWK $2.24
- NAUT N/A
- Revenue Growth
- WHWK 16.51
- NAUT N/A
- 52 Week Low
- WHWK $1.21
- NAUT $0.66
- 52 Week High
- WHWK $3.81
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- WHWK N/A
- NAUT 54.99
- Support Level
- WHWK N/A
- NAUT $0.74
- Resistance Level
- WHWK N/A
- NAUT $0.82
- Average True Range (ATR)
- WHWK 0.00
- NAUT 0.07
- MACD
- WHWK 0.00
- NAUT 0.01
- Stochastic Oscillator
- WHWK 0.00
- NAUT 71.09
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.